The concentrations of NfL and GFAP were found to be elevated in 405 non-hospitalized COVID-19 patients [20], with plasma GFAP levels observed to be significantly two-fold higher in critically ill patients with COVID-19 when compared to healthy controls [17]. Here, GFAP is linked to COVID-19.